Poland· PL-100019456

Diprophos

A betamethasone product containing betamethasoni dipropionas + betamethasoni natrii phosphas, registered in Poland by Organon Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC H02AB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDiprophosATCH02AB01REGISTER NO.PL-100019456PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Betamethasone is registered in 12 of 19 countries.

Countries holding a registration under ATC H02AB01 (betamethasone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Betamethasone · ATC H02AB01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of betamethasone costs, country by country.

Normalised to the WHO defined daily dose (1.5 mg), the median price runs from $0.34 in Italy to $1.42 in Switzerland — a ×4.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Betamethasone · price per daily dose (1.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.42
  • IT Italy$0.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Betamethasoni dipropionas + Betamethasoni natrii phosphas
Manufacturer
Organon Polska Sp. z o.o.
Country
Poland (PL)
ATC code
H02AB01
ATC class
Betamethasone
Defined daily dose
1.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909990121625
    5 ampułek po 1 ml
    PLN 97.2
  • gtin
    05909990121618

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

509 interactions on record for betamethasone.

Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Betamethasone · interactions on record

509 records

  • 55 severe
  • 391 moderate
  • 43 minor

Most severe, free to view

  • DesirudinB01AE01severe
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • AprepitantA04AD12moderate

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Betamethasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betamethasone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Betnesol, Betnovate
  • Belgium · Betnelan V, Celestone
  • Bulgaria · Бетазон, Бетазонтаб
  • Cyprus · Betnovate, Medobeta
  • Czechia · Beloderm, Diprosone
  • Germany · Betagalen, Betagalen Lotion
  • Denmark · Bekuval, Bemeson
  • Estonia · Betnovate
  • Spain · Betametasona Sonphar, Betnovate Crema
  • Finland · Bemetson, Betapred
  • France · Betamethasone Arrow, Betamethasone Biogaran
  • United Kingdom (Northern Ireland) · Audavate, Audavate Rd
  • Greece · Betnovate, Flogozyme
  • Croatia · Beloderm, Betamethasone Jgl
  • Hungary · Betesil
  • Ireland · Betacap Scalp Application, Betnovate
  • Iceland · Betnovat
  • Italy · Betamesol, Betametasone Dipropionato Sandoz
  • Lithuania · Celestoderm–v
  • Luxembourg · Betnelan V, Celestone
  • Latvia · Celestoderm-V
  • Malta · Betnovate
  • Netherlands · Betamethason Teva, Betamethason Xiromed
  • Norway · Betnovat, Diprotit
  • Portugal · Betametasona Basi, Betnovate
  • Romania · Betaderm, Betametazonă Fiterman
  • Sweden · Betametason Evolan, Betapred
  • Slovenia · Beloderm, Flosteron
  • Slovakia · Beloderm, Beloderm Lotion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdf928d4-17af-4baf-9515-2caf201a755f
GET /v1/drugs/bdf928d4-17af-4baf-9515-2caf201a755f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań",
  "source": "urpl",
  "strength": "(6,43 mg + 2,63 mg)/ml",
  "packaging": "05909990121618 ¦ Rp ¦ 3229\n1 amp. 1 ml\n05909990121625 ¦ Rp ¦ 3230\n5 amp. 1 ml",
  "substance": "Betamethasoni dipropionas 6.43 mg/ml + Betamethasoni natrii phosphas 2.63 mg/ml",
  "common_name": "Betamethasoni dipropionas + Betamethasoni natrii phosphas",
  "pl_product_id": "100019456",
  "pozwolenie_nr": "01216",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about betamethasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.